OXFORD & NEWCASTLE, England--(BUSINESS WIRE)--Drug discovery and development company e-Therapeutics plc (AIM: ETX) today provides an update on its goals and expectations for 2012.
•Four drugs to enter clinical trials ?ETS2101 (anti-cancer drug; phase I programme starting in Q1) ?ETX1153c (phase I trial for C. difficile infection starting in Q2)
